Clinical Safety And Therapeutic Efficacy Of Autologous Bone-Marrow Derived Stem Cells In Restoring Glycemic Control And Treating Complications In Diabetic Patients

In a groundbreaking study, researchers are now exploring the potential of using a patient’s own bone marrow-derived stem cells to provide stem cell therapy for managing diabetes – essentially harnessing the body’s own power! 💪

Here are some key insights…

✅ A Safer Approach: Could using a patient’s own bone marrow stem cells (autologous BMMNCs) offer a potentially safer route for diabetes therapy by minimizing risks seen with donor cells?

✅Potential for Better Control: Clinical studies suggest autologous BMMNC infusion holds promise for improving blood sugar levels (HbA1c) and possibly reducing insulin needs in Type 1 & Type 2 Diabetes.

✅ Hope for Patients with Complications: This therapy shows potential for addressing difficult diabetes-related issues e.g. conditions like kidney problems (nephropathy) or non-healing foot ulcers.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/